Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 29.40
+0.13 (0.44%)
Sep 1, 2026, 4:00 PM EDT
SHE:301166 Market Cap
SHE:301166 has a market cap or net worth of 2.51 billion as of September 1, 2026. Its market cap has decreased by -8.52% in one year.
Market Cap
2.51B
Enterprise Value
1.51B
Revenue
1.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.40
ChartMarket Cap Chart
Since December 28, 2021, SHE:301166's market cap has decreased from 9.10B to 2.51B, a decrease of -72.47%. That is a compound annual growth rate of -24.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.51B | -1.52% |
| Dec 31, 2025 | 2.54B | 3.97% |
| Dec 31, 2024 | 2.45B | -26.49% |
| Dec 29, 2023 | 3.33B | -15.99% |
| Dec 30, 2022 | 3.96B | -55.60% |
| Dec 31, 2021 | 8.93B | -1.94% |
| Dec 28, 2021 | 9.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Shouxiangu Pharmaceutical | 2.93B |
| Shandong Sito Bio-technology | 2.79B |
| Hubei Goto Biopharm Group | 2.76B |
| Guangdong VTR Bio-Tech | 2.74B |
| Landfar Bio-medicine | 2.71B |
| Shenzhen Bioeasy Biotechnology | 2.69B |
| Yantai Zhenghai Biotechnology | 2.66B |
| Zhejiang East Asia Pharmaceutical | 2.44B |